# Silva Paul M: insider transactions

SEC CIK 1446372. Roles and transactions as reported on Form 4. Latest Form 4 filed 2026-10-22.

## Roles

| Company | Role | Transactions | First | Latest |
| --- | --- | ---: | --- | --- |
| [Rapport Therapeutics, Inc.](/companies/rapp.md) | Director | 1 | 2026-10-22 | 2026-10-22 |

## Transactions: 1

Every transaction reported, newest first. Codes P and S are open-market purchases and sales. Reported price is as stated on the form.

| Date | Company | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-22 | [Rapport Therapeutics, Inc.](/companies/rapp.md) | Purchase (P) | 3,680 | $27.075 | $99.6k | [Form 4](/filings/0001193125-26-429075.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 30, 2026, 23:03 ET. No prices; not investment advice.